Inmaculada Hernandez Delso

Title(s)Professor, School of Pharmacy and Pharmaceutical Science
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
Emailinhernandez@ucsd.edu
ORCID ORCID Icon0000-0002-0118-4986 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Pittsburgh, Pittsburgh, PAPhD06/2016Health Services Research and Policy
    University of Navarra, Pamplona (Spain)International graduate-level pharmacy degree equivalent to US PharmD06/2013Pharmacy
    Pompeu i Fabra University, Barcelona (Spain)MS12/2013Health Economics and Pharmacoeconomics
    Collapse Awards and Honors
    National Academy of Medicine2022  - 2024National Academy of Medicine Fellow in Pharmacy
    Forbes2018Forbes 30 Under 30
    Academy Health2021Alice S. Hersh Emerging Leader Award
    American Journal of Managed Care2019Seema S. Sonnad Emerging Leader in Managed Care Research Award
    American College of Cardiology2018Fellow
    American Heart Association2019Fellow
    Rho Chi Society2019Outstanding Scholarly Contribution Award
    Delta Omega National Public Health Honor Society Omicron Chapter 2017Best Doctoral Dissertation Award
    Journal of Managed Care and Specialty Pharmacy 2022Journal of Managed Care and Specialty Pharmacy Award for Excellence
    Delta Omega Honorary Society2019Delta Omega Public Health Honor Society Inductee
    Journal of the American Pharmacists Association2023Outstanding Contribution in Authorship
    PhRMA Foundation 2023Challenge Award for Addressing Unanswered Questions in Medicare Drug Price Negotiations

    Collapse Overview 
    Collapse Overview
    Inmaculada (Inma) Hernandez is a Professor with tenure at the University of California, San Diego. Her research program sits at the intersection of health services research, pharmaceutical policy, and pharmacoepidemiology. Hernandez has authored over 100 scientific articles (>80 as first or senior author), including first-authored papers in JAMA, JAMA Internal Medicine or Annals of Internal Medicine, among other leading journals. Her scientific contributions have been covered by media worldwide and have been featured by the main outlets, including New York Times, Washington Post, NPR, CNN, Forbes, or BBC.

    Hernandez is a nationally recognized pharmaceutical policy scholar who has made major contributions to improving transparency in the drug pricing and reimbursement system. She was the first to quantify the contribution of innovation versus inflation in the rising trends of drug prices. In 2020, she documented in JAMA the increasingly large disconnect between the list prices of medications and manufacturers’ net revenue, which is the product of confidential rebates. In order to shed light into these opaque pricing dynamics, Hernandez developed an algorithm in collaboration with Sean Dickson that leverages multiple datasets to track cash flow across the drug supply chain. This algorithm produced the first public estimates of confidential manufacturer discounts to pharmacy benefit managers for leading drug products.

    Hernandez maintains a NIH-funded research program focused on the application of advanced methods and large datasets to optimize medication use in older adults. These pharmaco-epidemiology efforts have centered on improving the use of anticoagulants to prevent strokes associated with atrial fibrillation, a common cardiac arrhythmia. Additionally, Hernandez has pioneered the execution of nationwide person-level geographic information systems (GIS) analysis to measure inequities in spatial accessibility to the health care infrastructure. This research line commenced in the setting of the COVID-19 pandemic with the development of an app that informed the Pennsylvania Department of Health in the distribution of COVID-19 vaccines to medically underserved areas.

    Hernandez was recognized on the Forbes 30 under 30 list in 2018 and in 2021 she became the first pharmacist to receive the Academy Health Alice S. Hersh Emerging Leader Award. She has been invited to testify before the Senate Finance Committee on pharmaceutical policy matters, and her research has been cited in high-profile policy documents, including ASPE, GAO, and MedPAC reports to Congress, CDC guidelines, FDA reports, NIH requests for information, and testimonies before both Chambers of Congress. Hernandez currently holds the National Academy of Medicine Fellowship in Pharmacy, and is a fellow of the American College of Cardiology and the American Heart Association.
    Collapse In The News

    Collapse Research 
    Collapse Research Activities and Funding
    Integrating Net Prices and Comparative Effectiveness Assessments for the Initial Price Offer
    The Commonwealth Fund Aug 1, 2023 - Dec 31, 2024
    Role: PI
    Effect of Extreme Heat and Wildfire Smoke on Health Outcomes and Costs in Vulnerable Populations with Cardiovascular Disease in the Western US: A Geospatial Analysis
    Skaggs Family Foundation Jul 1, 2023 - Jun 30, 2025
    Role: MPI
    Pricing and Discounting Dynamics Associated with Significant Events over the Life Cycle of a Drug
    West Health Policy Center Aug 25, 2022 - Dec 31, 2024
    Role: PI
    Effect of Competition on Pharmaceutical Manufacturer Discounts and Prices
    West Health Policy Center Sep 1, 2021 - Aug 31, 2022
    Role: PI
    Pandemic Disruptions of Atrial Fibrillation Care
    NIH R01HL157051Jul 1, 2021 - Jun 30, 2025
    Role: PI
    Patient and System-Level Determinants of Oral Anticoagulation Use in Atrial Fibrillation
    NIH K01HL142847Jul 15, 2018 - Jun 30, 2023
    Role: PI

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A Retrospective Cohort Study of the 2018 Angiotensin Receptor Blocker Recalls and Subsequent Drug Shortages in Patients With Hypertension. J Am Heart Assoc. 2024 Jan 02; 13(1):e032266. Devine JW, Tadrous M, Hernandez I, Callaway Kim K, Rothenberger SD, Mukhopadhyay N, Gellad WF, Suda KJ. PMID: 38156554; PMCID: PMC10863811.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Reimbursement to Pharmacies for Generic Drugs by Medicare Part D Sponsors. JAMA. 2023 12 26; 330(24):2390-2392. Hernandez I, Gabriel N, Kaltenboeck A, Boccuti C, Hansen RN, Sullivan SD. PMID: 38051277; PMCID: PMC10698681.
      View in: PubMed   Mentions:    Fields:    
    3. Medicare drug price negotiation: The complexities of selecting therapeutic alternatives for estimating comparative effectiveness. J Manag Care Spec Pharm. 2024 Mar 01; 30(3):218-225. Hernandez I, Cousin EM, Wouters OJ, Gabriel N, Cameron T, Sullivan SD. PMID: 38088899.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Individual and social determinants of adherence to sodium-glucose cotransporter 2 inhibitor therapy: A trajectory analysis. J Manag Care Spec Pharm. 2023 Nov; 29(11):1242-1251. Yang L, Gabriel N, Bian J, Bilello LA, Wright DR, Hernandez I, Guo J. PMID: 37889868; PMCID: PMC10776261.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Changes In Net Prices And Spending For Pharmaceuticals After The Introduction Of New Therapeutic Competition, 2011-19. Health Aff (Millwood). 2023 08; 42(8):1062-1070. Dickson S, Gabriel N, Hernandez I. PMID: 37549318.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    6. Association Between Redlining and Spatial Access to Pharmacies. JAMA Netw Open. 2023 08 01; 6(8):e2327315. Appolon G, Tang S, Gabriel N, Morales J, Berenbrok LA, Guo J, Hernandez I. PMID: 37540516; PMCID: PMC10403774.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    7. A Real-World Evaluation of Primary Medication Nonadherence in Patients with Nonvalvular Atrial Fibrillation Prescribed Oral Anticoagulants in the United States. Am J Cardiovasc Drugs. 2023 Sep; 23(5):559-572. Hernandez I, Divino V, Xie L, Hood DW, DeKoven M, Kariuki W, Bell G, Russ C, Cheng D, Cato M, Atreja N, Hines DM. PMID: 37301789.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Association between distance to community health care facilities and COVID-19-related mortality across U.S. counties in the COVID-19-vaccine era. BMC Res Notes. 2023 Jun 05; 16(1):96. Huang W, Hernandez I, Tang S, Dickson S, Berenbrok LA, Guo J. PMID: 37277859; PMCID: PMC10241387.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Estimated Changes in Insulin Prices and Discounts After Entry of New Insulin Products, 2012-2019. JAMA Health Forum. 2023 Jun 02; 4(6):e231430. Dickson S, Gabriel N, Gellad WF, Hernandez I. PMID: 37327008; PMCID: PMC10276305.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    10. Assessment of Commercial and Mandatory Discounts in the Gross-to-Net Bubble for the Top Insulin Products From 2012 to 2019. JAMA Netw Open. 2023 06 01; 6(6):e2318145. Dickson SR, Gabriel N, Gellad WF, Hernandez I. PMID: 37314806; PMCID: PMC10267767.
      View in: PubMed   Mentions: 6     Fields:    
    11. Evaluation of Out-of-Pocket Costs and Treatment Intensification With an SGLT2 Inhibitor or GLP-1 RA in Patients With Type 2 Diabetes and Cardiovascular Disease. JAMA Netw Open. 2023 06 01; 6(6):e2317886. Luo J, Feldman R, Callaway Kim K, Rothenberger S, Korytkowski M, Hernandez I, Gellad WF. PMID: 37307000; PMCID: PMC10261995.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    12. Cost-effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction. JAMA Cardiol. 2023 05 01; 8(5):419-428. Cohen LP, Isaza N, Hernandez I, Lewis GD, Ho JE, Fonarow GC, Kazi DS, Bellows BK. PMID: 36870047; PMCID: PMC9985815.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    13. Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020. JAMA Cardiol. 2023 05 01; 8(5):443-452. Jacobs JA, Addo DK, Zheutlin AR, Derington CG, Essien UR, Navar AM, Hernandez I, Lloyd-Jones DM, King JB, Rao S, Herrick JS, Bress AP, Pandey A. PMID: 36947031; PMCID: PMC10034667.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    14. Racial disparities in access to health care infrastructure across US counties: A geographic information systems analysis. Front Public Health. 2023; 11:897007. Guo J, Dickson S, Berenbrok LA, Tang S, Essien UR, Hernandez I. PMID: 37113167; PMCID: PMC10126491.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. A Prescription for Achieving Equitable Access to Antiobesity Medications. JAMA Health Forum. 2023 04 07; 4(4):e230493. Wright DR, Guo J, Hernandez I. PMID: 37083822.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Variation in Statewide Intravesical Treatment Rates for Non-Muscle Invasive Bladder Cancer During the Bacillus Calmette-Guerin Drug Shortage. Urology. 2023 Jul; 177:74-80. Chun B, He M, Jones C, Vasan R, Gabriel N, Jacobs BL, Hernandez I, Davies BJ. PMID: 36972766.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Drugs likely subject to Medicare negotiation, 2026-2028. J Manag Care Spec Pharm. 2023 Mar; 29(3):229-235. Dickson S, Hernandez I. PMID: 36840960; PMCID: PMC10387900.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    18. COVID-19 pandemic and trends in new diagnosis of atrial fibrillation: A nationwide analysis of claims data. PLoS One. 2023; 18(2):e0281068. Hernandez I, He M, Guo J, Tadrous M, Gabriel N, Swabe G, Gellad WF, Essien UR, Saba S, Benjamin EJ, Magnani JW. PMID: 36730318; PMCID: PMC9894497.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    19. Transforming Atrial Fibrillation Research to Integrate Social Determinants of Health: A National Heart, Lung, and Blood Institute Workshop Report. JAMA Cardiol. 2023 02 01; 8(2):182-191. Benjamin EJ, Thomas KL, Go AS, Desvigne-Nickens P, Albert CM, Alonso A, Chamberlain AM, Essien UR, Hernandez I, Hills MT, Kershaw KN, Levy PD, Magnani JW, Matlock DD, O'Brien EC, Rodriguez CJ, Russo AM, Soliman EZ, Cooper LS, Al-Khatib SM. PMID: 36478155; PMCID: PMC10993288.
      View in: PubMed   Mentions: 4     Fields:    
    20. Association of New Use of Antihypertensives That Stimulate vs Inhibit Type 2 and 4 Angiotensin II Receptors With Dementia Among Medicare Beneficiaries. JAMA Netw Open. 2023 01 03; 6(1):e2249370. Marcum ZA, Gabriel N, Bress AP, Hernandez I. PMID: 36598787; PMCID: PMC9856661.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    21. Underprescribing vs underfilling to oral anticoagulation: An analysis of linked medical record and claims data for a nationwide sample of patients with atrial fibrillation. J Manag Care Spec Pharm. 2022 Dec; 28(12):1400-1409. Guo JS, He M, Gabriel N, Magnani JW, Kimmel SE, Gellad WF, Hernandez I. PMID: 36427343; PMCID: PMC10276659.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    22. COVID-19 and adherence to biologic therapies for psoriasis: An analysis of nationwide pharmacy claims data. J Manag Care Spec Pharm. 2022 Nov; 28(11):1213-1218. He M, Ferris LK, Gabriel N, Tadrous M, Hernandez I. PMID: 36282925; PMCID: PMC10284347.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    23. Spending on Insulin by U.S. Payers and Patients From 2008 to 2017. Diabetes Care. 2022 Nov 01; 45(11):e163-e164. Chiu N, Aggarwal R, Hernandez I, Wadhera R, Dejong C, Tseng CW, Yeh RW, Kazi DS. PMID: 36041194.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    24. Pharmaceutical Spending in Fee-for-Service Medicare: Looking Ahead to the Inflation Reduction Act. JAMA. 2022 10 18; 328(15):1502-1503. Gellad WF, Hernandez I. PMID: 36255438.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Estimated changes in price discounts for tenofovir-inclusive HIV treatments following introduction of tenofovir alafenamide. AIDS. 2022 12 01; 36(15):2225-2227. Dickson S, Gabriel N, Hernandez I. PMID: 36205353; PMCID: PMC9698192.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    26. Association of Research and Development Investments With Treatment Costs for New Drugs Approved From 2009 to 2018. JAMA Netw Open. 2022 09 01; 5(9):e2218623. Wouters OJ, Berenbrok LA, He M, Li Y, Hernandez I. PMID: 36156148; PMCID: PMC9513642.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    27. Disparities in distribution of COVID-19 vaccines across US counties: A geographic information system-based cross-sectional study. PLoS Med. 2022 07; 19(7):e1004069. Hernandez I, Dickson S, Tang S, Gabriel N, Berenbrok LA, Guo J. PMID: 35901171; PMCID: PMC9333439.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    28. Access to community pharmacies: A nationwide geographic information systems cross-sectional analysis. J Am Pharm Assoc (2003). 2022 Nov-Dec; 62(6):1816-1822.e2. Berenbrok LA, Tang S, Gabriel N, Guo J, Sharareh N, Patel N, Dickson S, Hernandez I. PMID: 35965233.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    29. Reduction in Medicaid Rebates Paid by Pharmaceutical Manufacturers for Outpatient Injected, Inhaled, Infused, Implanted, or Instilled Drugs: The 5i Loophole. J Health Polit Policy Law. 2022 Jul 14. Dickson S, Gabriel N, Gellad W, Hernandez I. PMID: 35867551.
      View in: PubMed   Mentions: 2     Fields:    
    30. Income disparities in driving distance to health care infrastructure in the United States: a geographic information systems analysis. BMC Res Notes. 2022 Jun 27; 15(1):225. Guo J, Hernandez I, Dickson S, Tang S, Essien UR, Mair C, Berenbrok LA. PMID: 35761413; PMCID: PMC9235217.
      View in: PubMed   Mentions:    Fields:    
    31. Consequences of forgoing prescription drug subsidies among low-income Medicare beneficiaries with diabetes. Health Serv Res. 2022 10; 57(5):1136-1144. Glynn A, Hernandez I, Roberts ET. PMID: 35430735; PMCID: PMC9441281.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    32. Association of formulary restrictions and initiation of an SGLT2i or GLP1-RA among Medicare beneficiaries with type 2 diabetes. Diabetes Res Clin Pract. 2022 May; 187:109855. Luo J, Gabriel N, Korytkowski M, Hernandez I, Gellad WF. PMID: 35346753; PMCID: PMC10767977.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    33. Identifying Patients at Risk of Acute Kidney Injury Among Medicare Beneficiaries With Type 2 Diabetes Initiating SGLT2 Inhibitors: A Machine Learning Approach. Front Pharmacol. 2022; 13:834743. Yang L, Gabriel N, Hernandez I, Vouri SM, Kimmel SE, Bian J, Guo J. PMID: 35359843; PMCID: PMC8961669.
      View in: PubMed   Mentions: 3  
    34. Effect of the COVID-19 pandemic on adversity in individuals receiving anticoagulation for atrial fibrillation: A nationally representative administrative health claims analysis. Am Heart J Plus. 2022 Jan; 13:100096. Hernandez I, Gabriel N, He M, Guo J, Tadrous M, Suda KJ, Magnani JW. PMID: 35136865; PMCID: PMC8815277.
      View in: PubMed   Mentions: 4  
    35. Comparison of oral anticoagulation use and adherence among Medicare beneficiaries enrolled in stand-alone prescription drug plans vs Medicare Advantage prescription drug plans. J Manag Care Spec Pharm. 2022 Feb; 28(2):266-274. Newman TV, Gabriel N, Liang Q, Drake C, El Khoudary SR, Good CB, Gellad WF, Hernandez I. PMID: 35098746; PMCID: PMC8856760.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    36. The global impact of COVID-19 on drug purchases: A cross-sectional time series analysis. J Am Pharm Assoc (2003). 2022 May-Jun; 62(3):766-774.e6. Suda KJ, Kim KC, Hernandez I, Gellad WF, Rothenberger S, Campbell A, Malliart L, Tadrous M. PMID: 35094929; PMCID: PMC8704785.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    37. COVID-19 and Anticoagulation for Atrial Fibrillation: An Analysis of US Nationwide Pharmacy Claims Data. J Am Heart Assoc. 2021 12 21; 10(24):e023235. Hernandez I, Gabriel N, He M, Guo J, Tadrous M, Suda KJ, Magnani JW. PMID: 34913359; PMCID: PMC9075244.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    38. Primary care provider payment models and adherence to anticoagulation in patients with atrial fibrillation. J Manag Care Spec Pharm. 2021 Dec; 27(12):1672-1679. Yang L, Guo J, Liang Q, Newman TV, Gellad WF, Hernandez I. PMID: 34818086; PMCID: PMC8856758.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    39. Racial and Urban-Rural Difference in the Frequency of Ischemic Stroke as Initial Manifestation of Atrial Fibrillation. Front Public Health. 2021; 9:780185. Guo J, Gabriel N, Magnani JW, Essien UR, Gellad WF, Brooks MM, Trinquart L, Benjamin EJ, Hernandez I. PMID: 34805085; PMCID: PMC8602106.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    40. Decomposition of Expenditures for Insulins Across the Distribution Chain-Insights Into Rising Prices? JAMA Health Forum. 2021 11 02; 2(11):e212258. Good CB, Hernandez I. PMID: 36218843.
      View in: PubMed   Mentions:    Fields:    
    41. Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA. Am J Cardiovasc Drugs. 2022 May; 22(3):333-343. Dhamane AD, Hernandez I, Di Fusco M, Gutierrez C, Ferri M, Russ C, Tsai WL, Emir B, Yuce H, Keshishian A. PMID: 34671944; PMCID: PMC9061668.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    42. Emerging treatments for lupus nephritis: health equity considerations in clinical research and coverage. J Manag Care Spec Pharm. 2021 Oct; 27(10):1500-1502. Newman TV, Guo J, Hernandez I. PMID: 34595947; PMCID: PMC10390942.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    43. Are novel glucose-lowering agents' cardiorenal benefits generalizable to individuals of Black race? A meta-trial sequential analysis to address disparities in cardiovascular and renal outcome trials enrolment. Diabetes Obes Metab. 2022 01; 24(1):154-159. Tang H, Kimmel SE, Hernandez I, Brooks MM, Cusi K, Smith SM, Shi W, Winterstein AG, Magnani JW, Guo J. PMID: 34472689.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    44. The Costs of Delayed Generic Drug Entry: Evidence from a Controversial Prostate Cancer Drug Patent. J Gen Intern Med. 2022 02; 37(3):668-670. Miller D, Ippolito B, Hernandez I, Davies B. PMID: 34258725; PMCID: PMC8858345.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    45. Cost-effectiveness of Dapagliflozin for the Treatment of Heart Failure With Reduced Ejection Fraction. JAMA Netw Open. 2021 07 01; 4(7):e2114501. Isaza N, Calvachi P, Raber I, Liu CL, Bellows BK, Hernandez I, Shen C, Gavin MC, Garan AR, Kazi DS. PMID: 34313742; PMCID: PMC8317009.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    46. Marked Increase in Sales of Erectile Dysfunction Medication During COVID-19. J Gen Intern Med. 2021 09; 36(9):2912-2914. Hernandez I, Gul Z, Gellad WF, Davies BJ. PMID: 34170453; PMCID: PMC8229258.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    47. Trends in the Use of Conventional and New Pharmaceuticals for Hemophilia Treatments Among Medicaid Enrollees, 2005-2020. JAMA Netw Open. 2021 06 01; 4(6):e2112044. Hernandez I, Rowe D, Gellad WF, Good CB. PMID: 34076701; PMCID: PMC8173373.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    48. A decade of increases in Medicare Part B pharmaceutical spending: what are the drivers? J Manag Care Spec Pharm. 2021 May; 27(5):565-573. San-Juan-Rodriguez A, Gellad WF, Shrank WH, Good CB, Hernandez I. PMID: 33908276; PMCID: PMC8906185.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    49. Joint Latent Class Analysis of Oral Anticoagulation Use and Risk of Stroke or Systemic Thromboembolism in Patients with Atrial Fibrillation. Am J Cardiovasc Drugs. 2021 Sep; 21(5):573-580. Chen N, Gabriel N, Brooks MM, Hernandez I. PMID: 33844177; PMCID: PMC8440356.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    50. Impact of the COVID-19 Pandemic on Global Anticoagulant Sales: A Cross-Sectional Analysis Across 39 Countries. Am J Cardiovasc Drugs. 2021 09; 21(5):581-583. Hernandez I, Tadrous M, Magnani JW, Guo J, Suda KJ. PMID: 33768423; PMCID: PMC7994109.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    51. Using machine learning to identify diabetes patients with canagliflozin prescriptions at high-risk of lower extremity amputation using real-world data. Pharmacoepidemiol Drug Saf. 2021 05; 30(5):644-651. Yang L, Gabriel N, Hernandez I, Winterstein AG, Guo J. PMID: 33606340.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    52. Association between opioid dose escalation and time to death in a comfort measures only population. Am J Health Syst Pharm. 2021 01 22; 78(3):203-209. Abraham DL, Hernandez I, Ayers GT, Pruskowski JA. PMID: 33064125; PMCID: PMC7797738.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    53. Trends in list prices, net prices, and discounts of self-administered injectable tumor necrosis factor inhibitors. J Manag Care Spec Pharm. 2021 Jan; 27(1):112-117. San-Juan-Rodriguez A, Piro VM, Good CB, Gellad WF, Hernandez I. PMID: 33377437; PMCID: PMC7788267.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    54. Coverage, Formulary Restrictions, and Out-of-Pocket Costs for Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Medicare Part D Program. JAMA Netw Open. 2020 10 01; 3(10):e2020969. Luo J, Feldman R, Rothenberger SD, Hernandez I, Gellad WF. PMID: 33057641; PMCID: PMC7563069.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    55. Trends in List and Net Prices of Self-administered Systemic Psoriasis Therapies Manufactured by US-Based Pharmaceutical Companies. JAMA Dermatol. 2020 10 01; 156(10):1136-1138. Ferris LK, Gellad WF, Hernandez I. PMID: 32785612; PMCID: PMC7557512.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    56. Effectiveness and Safety of Restarting Oral Anticoagulation in Patients with Atrial Fibrillation after an Intracranial Hemorrhage: Analysis of Medicare Part D Claims Data from 2010-2016. Am J Cardiovasc Drugs. 2020 Oct; 20(5):471-479. Newman TV, Chen N, He M, Saba S, Hernandez I. PMID: 31808136; PMCID: PMC7274872.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    57. Estimating Discounts for Top Spending Drugs in Medicare Part D. J Gen Intern Med. 2021 08; 36(8):2503-2505. Hernandez I, San-Juan-Rodriguez A, Good CB, Gellad WF. PMID: 32909227; PMCID: PMC8342628.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    58. Drug Shortages and Group Purchasing Organizations-Reply. JAMA. 2020 08 25; 324(8):809. Donohue JM, Hernandez I, Hershey TB. PMID: 32840590.
      View in: PubMed   Mentions: 1     Fields:    
    59. Drug Prices, Rebates, and Discounts-Reply. JAMA. 2020 07 28; 324(4):399-400. Hernandez I, Gellad WF. PMID: 32721000.
      View in: PubMed   Mentions:    Fields:    
    60. Evaluation of Frequency of Encounters With Primary Care Physicians vs Visits to Community Pharmacies Among Medicare Beneficiaries. JAMA Netw Open. 2020 07 01; 3(7):e209132. Berenbrok LA, Gabriel N, Coley KC, Hernandez I. PMID: 32667653; PMCID: PMC7364370.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    61. Comparison of Oral Anticoagulant Use and Stroke Risk Among Older Adults Newly-Diagnosed Atrial Fibrillation Living in Urban-Versus-Rural Areas. Am J Cardiol. 2020 09 01; 130:64-69. Guo J, He M, Magnani JW, Brooks MM, Gellad WF, Hernandez I. PMID: 32680675; PMCID: PMC8040970.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    62. Interpreting COVID-19 Test Results: a Bayesian Approach. J Gen Intern Med. 2020 08; 35(8):2490-2491. Good CB, Hernandez I, Smith K. PMID: 32495086; PMCID: PMC7269418.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsPHPublic Health
    63. The Skyrocketing Cost of Rectal Indomethacin. JAMA Intern Med. 2020 05 01; 180(5):631-632. Elmunzer BJ, Hernandez I, Gellad WF. PMID: 32150228; PMCID: PMC7483935.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    64. Real-World Direct Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Medicare Beneficiaries With Atrial Fibrillation. Am J Cardiol. 2020 07 01; 126:29-36. Yang L, Brooks MM, Glynn NW, Zhang Y, Saba S, Hernandez I. PMID: 32359718; PMCID: PMC7275920.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    65. Adherence to Anticoagulation and Risk of Stroke Among Medicare Beneficiaries Newly Diagnosed with Atrial Fibrillation. Am J Cardiovasc Drugs. 2020 Apr; 20(2):199-207. Hernandez I, He M, Brooks MM, Saba S, Gellad WF. PMID: 31523759; PMCID: PMC7073283.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    66. Drug Shortages in the United States: Are Some Prices Too Low? JAMA. 2020 Mar 03; 323(9):819-820. Hernandez I, Hershey TB, Donohue JM. PMID: 32125409; PMCID: PMC7099531.
      View in: PubMed   Mentions: 4     Fields:    
    67. Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018. JAMA. 2020 03 03; 323(9):854-862. Hernandez I, San-Juan-Rodriguez A, Good CB, Gellad WF. PMID: 32125403; PMCID: PMC7054846.
      View in: PubMed   Mentions: 47     Fields:    
    68. Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data. J Natl Med Assoc. 2020 Feb; 112(1):103-108. Essien UR, Magnani JW, Chen N, Gellad WF, Fine MJ, Hernandez I. PMID: 32035755; PMCID: PMC7183759.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    69. Latent Classes of Adherence to Oral Anticoagulation Therapy Among Patients With a New Diagnosis of Atrial Fibrillation. JAMA Netw Open. 2020 02 05; 3(2):e1921357. Chen N, Brooks MM, Hernandez I. PMID: 32074287; PMCID: PMC7081375.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    70. Differences Between Managed Care and Fee-for-Service Medicaid in the Use of Generics for High-Rebate Drugs: The Cases of Insulin Glargine and Glatiramer. J Manag Care Spec Pharm. 2020 Feb; 26(2):154-159. Hernandez I, Gellad WF. PMID: 32011961; PMCID: PMC7026907.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    71. Impact of community pharmacist-led interventions in chronic disease management on clinical, utilization, and economic outcomes: An umbrella review. Res Social Adm Pharm. 2020 09; 16(9):1155-1165. Newman TV, San-Juan-Rodriguez A, Parekh N, Swart ECS, Klein-Fedyshin M, Shrank WH, Hernandez I. PMID: 31959565.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    72. Impact of Healthcare Delivery System Type on Clinical, Utilization, and Cost Outcomes of Patient-Centered Medical Homes: a Systematic Review. J Gen Intern Med. 2020 04; 35(4):1276-1284. Veet CA, Radomski TR, D'Avella C, Hernandez I, Wessel C, Swart ECS, Shrank WH, Parekh N. PMID: 31907790; PMCID: PMC7174518.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    73. Risk Factors for Cardiovascular Events in Patients on Antidementia Medications. Am J Alzheimers Dis Other Demen. 2020 Jan-Dec; 35:1533317520922380. He M, Stevenson JM, Zhang Y, Hernandez I. PMID: 32383387; PMCID: PMC7315406.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    74. Impact of direct-to-consumer drug advertising during the Super Bowl on drug utilization. Res Social Adm Pharm. 2020 08; 16(8):1136-1139. Gray MP, San-Juan-Rodriguez A, Chen N, Good CB, Hernandez I. PMID: 31864886; PMCID: PMC6939613.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    75. Trends in List Prices, Net Prices, and Discounts for Originator Biologics Facing Biosimilar Competition. JAMA Netw Open. 2019 12 02; 2(12):e1917379. San-Juan-Rodriguez A, Gellad WF, Good CB, Hernandez I. PMID: 31834391; PMCID: PMC6938676.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    76. Trends in Prices, Market Share, and Spending on Self-administered Disease-Modifying Therapies for Multiple Sclerosis in Medicare Part D. JAMA Neurol. 2019 Nov 01; 76(11):1386-1390. San-Juan-Rodriguez A, Good CB, Heyman RA, Parekh N, Shrank WH, Hernandez I. PMID: 31449293; PMCID: PMC6714023.
      View in: PubMed   Mentions: 18     Fields:    
    77. Varenicline and Nicotine Replacement Use Associated With US Food and Drug Administration Drug Safety Communications. JAMA Netw Open. 2019 09 04; 2(9):e1910626. Desai RJ, Good MM, San-Juan-Rodriguez A, Henriksen A, Cunningham F, Hernandez I, Good CB. PMID: 31483473; PMCID: PMC6754175.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    78. Optimizing the Role of Community Pharmacists in Managing the Health of Populations: Barriers, Facilitators, and Policy Recommendations. J Manag Care Spec Pharm. 2019 09; 25(9):995-1000. Newman TV, Hernandez I, Keyser D, San-Juan-Rodriguez A, Swart ECS, Shrank WH, Parekh N. PMID: 31456493; PMCID: PMC10397707.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    79. Savings from the EpiPen Authorized Generic: a Retrospective Analysis of Medicaid Data. J Gen Intern Med. 2019 09; 34(9):1682-1684. Hernandez I, Shrank WH, Good CB, Gellad WF. PMID: 30945066; PMCID: PMC6712184.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    80. Impact of Star Rating Medication Adherence Measures on Adherence for Targeted and Nontargeted Medications. Value Health. 2019 11; 22(11):1266-1274. Parekh N, Munshi KD, Hernandez I, Gellad WF, Henderson R, Shrank WH. PMID: 31708063.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    81. Statins for Primary Prevention of Cardiovascular Disease. Ann Intern Med. 2019 07 02; 171(1):72. Good CB, Hernandez I, Parekh N. PMID: 31261394.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    82. Number of manufacturers and generic drug pricing from 2005 to 2017. Am J Manag Care. 2019 07; 25(7):348-352. Hernandez I, Good CB, Gellad WF, Parekh N, He M, Shrank WH. PMID: 31318508; PMCID: PMC6734551.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    83. Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation. J Am Heart Assoc. 2019 06 18; 8(12):e011427. Hernandez I, He M, Chen N, Brooks MM, Saba S, Gellad WF. PMID: 31189392; PMCID: PMC6645643.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    84. Assessment of Price Changes of Existing Tumor Necrosis Factor Inhibitors After the Market Entry of Competitors. JAMA Intern Med. 2019 05 01; 179(5):713-716. San-Juan-Rodriguez A, Prokopovich MV, Shrank WH, Good CB, Hernandez I. PMID: 30776053; PMCID: PMC6503568.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    85. Trends in Medicaid Prices, Market Share, and Spending on Long-Acting Insulins, 2006-2018. JAMA. 2019 04 23; 321(16):1627-1629. Hernandez I, Good CB, Shrank WH, Gellad WF. PMID: 30907933; PMCID: PMC6487544.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    86. Cardiac resynchronization therapy using pacemakers vs defibrillators in patients with nonischemic cardiomyopathy: The United States experience from 2007 to 2014. Heart Rhythm. 2019 07; 16(7):1065-1071. Saba S, McLaughlin T, He M, Althouse A, Mulukutla S, Hernandez I. PMID: 31004781.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    87. Association of Antidementia Therapies With Time to Skilled Nursing Facility Admission and Cardiovascular Events Among Elderly Adults With Alzheimer Disease. JAMA Netw Open. 2019 03 01; 2(3):e190213. San-Juan-Rodriguez A, Zhang Y, He M, Hernandez I. PMID: 30821828; PMCID: PMC6484658.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    88. The Contribution Of New Product Entry Versus Existing Product Inflation In The Rising Costs Of Drugs. Health Aff (Millwood). 2019 01; 38(1):76-83. Hernandez I, Good CB, Cutler DM, Gellad WF, Parekh N, Shrank WH. PMID: 30615532.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    89. Avoiding rash decisions about zoster vaccination: insights from cost-effectiveness evidence. BMC Med. 2018 12 18; 16(1):238. Good CB, Parekh N, Hernandez I. PMID: 30558674; PMCID: PMC6298010.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    90. Relationships between provider-led health plans and quality, utilization, and satisfaction. Am J Manag Care. 2018 12; 24(12):628-632. Parekh N, Hernandez I, Radomski TR, Shrank WH. PMID: 30586496.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    91. Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy-Reply. JAMA Oncol. 2018 12 01; 4(12):1785-1786. Hernandez I, Prasad V, Gellad WF. PMID: 30325998.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    92. Changes in Drug Pricing After Drug Shortages in the United States. Ann Intern Med. 2019 01 01; 170(1):74-76. Hernandez I, Sampathkumar S, Good CB, Kesselheim AS, Shrank WH. PMID: 30242373.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    93. Lowering the P Value Threshold. JAMA. 2018 09 04; 320(9):935. Hernandez I, Gellad WF, Good CB. PMID: 30193271.
      View in: PubMed   Mentions: 2     Fields:    
    94. Impact of community pharmacist-provided preventive services on clinical, utilization, and economic outcomes: An umbrella review. Prev Med. 2018 10; 115:145-155. San-Juan-Rodriguez A, Newman TV, Hernandez I, Swart ECS, Klein-Fedyshin M, Shrank WH, Parekh N. PMID: 30145351.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansPHPublic Health
    95. Comparing state, regional, and local variation in concurrent opioid and benzodiazepine use. Drug Alcohol Depend. 2018 10 01; 191:141-144. Hernandez I, He M, Zhang Y. PMID: 30099175.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    96. Comparing the Cost Effectiveness of Non-vitamin K Antagonist Oral Anticoagulants with Well-Managed Warfarin for Stroke Prevention in Atrial Fibrillation Patients at High Risk of Bleeding. Am J Cardiovasc Drugs. 2018 Aug; 18(4):317-325. Hospodar AR, Smith KJ, Zhang Y, Hernandez I. PMID: 29740750.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    97. Total Costs of Chimeric Antigen Receptor T-Cell Immunotherapy. JAMA Oncol. 2018 07 01; 4(7):994-996. Hernandez I, Prasad V, Gellad WF. PMID: 29710129; PMCID: PMC6145722.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    98. Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine. JAMA Intern Med. 2018 06 01; 178(6):873. Good CB, Hernandez I. PMID: 29868745.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    99. Exposure-Response Association Between Concurrent Opioid and Benzodiazepine Use and Risk of Opioid-Related Overdose in Medicare Part D Beneficiaries. JAMA Netw Open. 2018 06 01; 1(2):e180919. Hernandez I, He M, Brooks MM, Zhang Y. PMID: 30646080; PMCID: PMC6324417.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    100. Teaching About the Health Care Industry Through Gamification. Am J Pharm Educ. 2018 May; 82(4):6422. Wolf C, Bott S, Hernandez I, Grieve L. PMID: 29867241; PMCID: PMC5972850.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    101. Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin, Stratified by Stroke Risk in Patients With Atrial Fibrillation. Am J Cardiol. 2018 07 01; 122(1):69-75. Hernandez I, Zhang Y, Saba S. PMID: 29681367.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    102. A cost-minimization analysis of dalbavancin compared to conventional therapy for the outpatient treatment of acute bacterial skin and skin-structure infections. Expert Opin Pharmacother. 2018 Mar; 19(4):319-325. Turco NJ, Kane-Gill SL, Hernandez I, Oleksiuk LM, D'Amico F, Pickering AJ. PMID: 29509504.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    103. Pricing of monoclonal antibody therapies: higher if used for cancer? Am J Manag Care. 2018 02; 24(2):109-112. Hernandez I, Bott SW, Patel AS, Wolf CG, Hospodar AR, Sampathkumar S, Shrank WH. PMID: 29461857.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    104. Outcomes of Patients With Atrial Fibrillation Newly Recommended for Oral Anticoagulation Under the 2014 American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline. J Am Heart Assoc. 2018 01 04; 7(1). Gray MP, Saba S, Zhang Y, Hernandez I. PMID: 29301756; PMCID: PMC5778974.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    105. Using predictive analytics and big data to optimize pharmaceutical outcomes. Am J Health Syst Pharm. 2017 Sep 15; 74(18):1494-1500. Hernandez I, Zhang Y. PMID: 28887351.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    106. Revisiting Outcomes-Based Pricing Propositions for the PCSK9 Inhibitor Evolocumab. JAMA Intern Med. 2017 09 01; 177(9):1388-1390. Hernandez I. PMID: 28783812; PMCID: PMC5818836.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    107. Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Newly Diagnosed Atrial Fibrillation. Am J Cardiol. 2017 Nov 15; 120(10):1813-1819. Hernandez I, Zhang Y, Saba S. PMID: 28864318.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    108. Geographic Variation in the Use of Oral Anticoagulation Therapy in Stroke Prevention in Atrial Fibrillation. Stroke. 2017 08; 48(8):2289-2291. Hernandez I, Saba S, Zhang Y. PMID: 28655815.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    109. Pharmaceutical Use and Spending Trend in Medicare Beneficiaries With Dementia, From 2006 to 2012. Gerontol Geriatr Med. 2017 Jan-Dec; 3:2333721417704946. Hernandez I, Zhang Y. PMID: 28474001; PMCID: PMC5407657.
      View in: PubMed   Mentions: 2  
    110. Comparing Adoption of Breakthrough and "Me-too" Drugs among Medicare Beneficiaries: A Case Study of Dipeptidyl Peptidase-4 Inhibitors. J Pharm Innov. 2017 Jun; 12(2):105-109. Hernandez I, Zhang Y. PMID: 28966696; PMCID: PMC5614454.
      View in: PubMed   Mentions: 2  
    111. Comparing the Approval and Coverage Decisions of New Oncology Drugs in the United States and Other Selected Countries. J Manag Care Spec Pharm. 2017 02; 23(2):247-254. Zhang Y, Hueser HC, Hernandez I. PMID: 28125371; PMCID: PMC10401695.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    112. Comparing Stroke and Bleeding with Rivaroxaban and Dabigatran in Atrial Fibrillation: Analysis of the US Medicare Part D Data. Am J Cardiovasc Drugs. 2017 Feb; 17(1):37-47. Hernandez I, Zhang Y. PMID: 27637493; PMCID: PMC6572759.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    113. Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation. Stroke. 2017 01; 48(1):159-166. Hernandez I, Zhang Y, Brooks MM, Chin PK, Saba S. PMID: 27909200; PMCID: PMC5183492.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    114. Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation at high risk of bleeding and normal kidney function. Thromb Res. 2017 Feb; 150:123-130. Hernandez I, Smith KJ, Zhang Y. PMID: 27771008.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    115. Evaluating the Initiation of Novel Oral Anticoagulants in Medicare Beneficiaries. J Manag Care Spec Pharm. 2016 Mar; 22(3):281-92. Baik SH, Hernandez I, Zhang Y. PMID: 27003558; PMCID: PMC5051348.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    116. Time to reconsider dabigatran 110 mg in the USA. Am J Cardiovasc Drugs. 2015 Oct; 15(5):307-9. Hernandez I. PMID: 26068887.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    117. Risk of Bleeding With Dabigatran in 2010-2011 Medicare Data. JAMA Intern Med. 2015 Jul; 175(7):1245-7. Hernandez I, Zhang Y. PMID: 26146922; PMCID: PMC4495572.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    118. Comparing clinical and economic outcomes of biologic and conventional medications in postmenopausal women with osteoporosis. J Eval Clin Pract. 2015 Oct; 21(5):840-7. Hernandez I, Zhang Y. PMID: 26059485; PMCID: PMC6614859.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    119. Risk of bleeding with dabigatran in atrial fibrillation. JAMA Intern Med. 2015 Jan; 175(1):18-24. Hernandez I, Baik SH, Piñera A, Zhang Y. PMID: 25365537; PMCID: PMC6608584.
      View in: PubMed   Mentions: 97     Fields:    Translation:Humans
    Inmaculada's Networks
    Concepts (323)
    Derived automatically from this person's publications.
    _
    Co-Authors (8)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _